Skip to main content
Erschienen in: Arthritis Research & Therapy 5/2000

01.08.2000 | Review

Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

verfasst von: Thomas Pap, Ulf Müller-Ladner, Renate E Gay, Steffen Gay

Erschienen in: Arthritis Research & Therapy | Ausgabe 5/2000

Einloggen, um Zugang zu erhalten

Abstract

There is growing evidence that activated synovial fibroblasts, as part of a complex cellular network, play an important role in the pathogenesis of rheumatoid arthritis. In recent years, significant progress has been made in elucidating the specific features of these fibroblasts. It has been understood that although macrophage and lymphocyte secreted factors contribute to their activation, rheumatoid arthritis synovial fibroblasts (RA-SFs) do not merely respond to stimulation by pro-inflammatory cytokines, but show a complex pattern of molecular changes also maintained in the absence of external stimulation. This pattern of activation is characterized by alterations in the expression of regulatory genes and signaling cascades, as well as changes in pathways leading to apoptosis. These together result in the upregulation of adhesion molecules that mediate the attachment of RA-SFs to the extracellular matrix and in the overexpression of matrix degrading enzymes that mediate the progressive destruction of the joints. In addition, activated RA-SFs exert specific effects on other cell types such as macrophages and lymphocytes. While the initiating step in the activation of RA-SFs remains elusive, several key pathways of RA-SF activation have been identified. However, there is so far no single, specific marker for this phenotype of RA-SF. It appears that activated RA-SFs are characterized by a set of specific properties which together lead to their aggressive behavior.
Literatur
1.
Zurück zum Zitat Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis. 1993, 52 (suppl 1): S39-S47.CrossRef Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis. 1993, 52 (suppl 1): S39-S47.CrossRef
2.
Zurück zum Zitat Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996, 39: 1781-1790.PubMedCrossRef Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996, 39: 1781-1790.PubMedCrossRef
3.
Zurück zum Zitat Pap T, Franz JK, Gay RE, Gay S: Has research on lymphocytes hindered progress in rheumatoid arthritis?. In Challenges in Rheumatoid Arthritis. Edited by Bird H, Snaith M. Oxford: Blackwell Science;. 1999 Pap T, Franz JK, Gay RE, Gay S: Has research on lymphocytes hindered progress in rheumatoid arthritis?. In Challenges in Rheumatoid Arthritis. Edited by Bird H, Snaith M. Oxford: Blackwell Science;. 1999
4.
Zurück zum Zitat Franz JK, Pap T, Müller-Ladner U, Gay RE, Burmester GR, Gay S: T-cell independent joint destruction. In T Cells in Arthritis. Edited by Miossec P, van-den BW, Firestein GS. Basel: Birkenhäuser,. 1998, 55-74. Franz JK, Pap T, Müller-Ladner U, Gay RE, Burmester GR, Gay S: T-cell independent joint destruction. In T Cells in Arthritis. Edited by Miossec P, van-den BW, Firestein GS. Basel: Birkenhäuser,. 1998, 55-74.
5.
Zurück zum Zitat Fassbender HG: Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res. 1983, 3: 141-155.PubMedCrossRef Fassbender HG: Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res. 1983, 3: 141-155.PubMedCrossRef
6.
Zurück zum Zitat Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL: Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989, 83: 1267-1276.PubMedPubMedCentralCrossRef Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL: Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989, 83: 1267-1276.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.PubMedPubMedCentral Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.PubMedPubMedCentral
8.
Zurück zum Zitat Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S: Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol. 1997, 158: 3492-3498.PubMed Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S: Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol. 1997, 158: 3492-3498.PubMed
9.
Zurück zum Zitat Nawrath M, Hummel KM, Pap T, Müller-Ladner U, Gay RE, Moelling K, Gay S: Effect of dominant negative mutants of raf -1 and c-myc on rheumatoid arthritis synovial fibroblasts in the SCID mouse model [abstract]. Arthritis Rheum. 1998, 41: S95-S95. Nawrath M, Hummel KM, Pap T, Müller-Ladner U, Gay RE, Moelling K, Gay S: Effect of dominant negative mutants of raf -1 and c-myc on rheumatoid arthritis synovial fibroblasts in the SCID mouse model [abstract]. Arthritis Rheum. 1998, 41: S95-S95.
10.
Zurück zum Zitat Pap T, Franz JK, Hummel KM, Jeisy E, Gay RE, Gay S: Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2000, 2: 59-65. 10.1186/ar69.PubMedPubMedCentralCrossRef Pap T, Franz JK, Hummel KM, Jeisy E, Gay RE, Gay S: Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2000, 2: 59-65. 10.1186/ar69.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, Hopf T, Welter C: Constitutive expression of c-fos and c-jun, over-expression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 298-304.PubMedPubMedCentralCrossRef Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, Hopf T, Welter C: Constitutive expression of c-fos and c-jun, over-expression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 298-304.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Grimbacher B, Aicher WK, Peter HH, Eibel H: Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR. Rheumatol Int. 1997, 17: 109-112. 10.1007/s002960050018.PubMedCrossRef Grimbacher B, Aicher WK, Peter HH, Eibel H: Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR. Rheumatol Int. 1997, 17: 109-112. 10.1007/s002960050018.PubMedCrossRef
13.
Zurück zum Zitat Knotny E, Ziolkowska M, Dudzinka E, Filipowicz-Sosnowska A, Ryzewska A: Modified expression of c-Fos and c-Jun proteins and production of interleukin-1 beta in patients with rheumatoid arthritis. Clin Exp Rheumatol. 1995, 13: 51-57. Knotny E, Ziolkowska M, Dudzinka E, Filipowicz-Sosnowska A, Ryzewska A: Modified expression of c-Fos and c-Jun proteins and production of interleukin-1 beta in patients with rheumatoid arthritis. Clin Exp Rheumatol. 1995, 13: 51-57.
14.
Zurück zum Zitat Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG, Gay S: Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int. 1992, 12: 53-59.PubMedCrossRef Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG, Gay S: Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int. 1992, 12: 53-59.PubMedCrossRef
15.
Zurück zum Zitat Asahara H, Fujisawa K, Kobata T, Hasunuma T, Maeda T, Asanuma M, Ogawa N, Inoue H, Sumida T, Nishioka K: Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 1997, 40: 912-918.PubMedCrossRef Asahara H, Fujisawa K, Kobata T, Hasunuma T, Maeda T, Asanuma M, Ogawa N, Inoue H, Sumida T, Nishioka K: Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 1997, 40: 912-918.PubMedCrossRef
16.
Zurück zum Zitat Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 1997, 15: 519-526. 10.1016/S0945-053X(97)90026-3.PubMedCrossRef Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 1997, 15: 519-526. 10.1016/S0945-053X(97)90026-3.PubMedCrossRef
17.
Zurück zum Zitat Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA. 1998, 95: 13859-13864. 10.1073/pnas.95.23.13859.PubMedPubMedCentralCrossRef Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA. 1998, 95: 13859-13864. 10.1073/pnas.95.23.13859.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Han Z, Boyle DL, Manning AM, Firestein GS: AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998, 28: 197-208.PubMedCrossRef Han Z, Boyle DL, Manning AM, Firestein GS: AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998, 28: 197-208.PubMedCrossRef
19.
Zurück zum Zitat Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA: Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996, 39: 583-591.PubMedCrossRef Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA: Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996, 39: 583-591.PubMedCrossRef
20.
Zurück zum Zitat Palombella VJ, Conner EM, Fuseler JW, Destree A, Davis JM, Laroux FS, Wolf RE, Huang J, Brand S, Elliott PJ, Lazarus D, McCormack T, Parent L, Stein R, Adams J, Grisham MB: Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci USA. 1998, 95: 15671-15676. 10.1073/pnas.95.26.15671.PubMedPubMedCentralCrossRef Palombella VJ, Conner EM, Fuseler JW, Destree A, Davis JM, Laroux FS, Wolf RE, Huang J, Brand S, Elliott PJ, Lazarus D, McCormack T, Parent L, Stein R, Adams J, Grisham MB: Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci USA. 1998, 95: 15671-15676. 10.1073/pnas.95.26.15671.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Vincenti MP, Coon CI, Brinckerhoff CE: Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum . 1998, 41: 1987-1994. 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#.PubMedCrossRef Vincenti MP, Coon CI, Brinckerhoff CE: Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum . 1998, 41: 1987-1994. 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#.PubMedCrossRef
22.
Zurück zum Zitat Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMedPubMedCentralCrossRef Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Pap T, Aupperle KR, Jeisy E, Gay RE, Firestein GS, Gay S: Inhibition of endogenous p53 by gene transfer increases the invasiveness of fibroblast-like synoviocytes in the SCID mouse model of rheumatoid arthritis (RA) [abstract]. Arthritis Rheum. 1999, 42: S163- Pap T, Aupperle KR, Jeisy E, Gay RE, Firestein GS, Gay S: Inhibition of endogenous p53 by gene transfer increases the invasiveness of fibroblast-like synoviocytes in the SCID mouse model of rheumatoid arthritis (RA) [abstract]. Arthritis Rheum. 1999, 42: S163-
24.
Zurück zum Zitat Kullmann F, Judex M, Neudecker I, Lechner S, Jüsten HP, Green DR, Wessinghage D, Firestein GS, Gay S, Schöllmerich J, Müller-Ladner U: Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 1999, 42: 1594-1600. 10.1002/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#.PubMedCrossRef Kullmann F, Judex M, Neudecker I, Lechner S, Jüsten HP, Green DR, Wessinghage D, Firestein GS, Gay S, Schöllmerich J, Müller-Ladner U: Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 1999, 42: 1594-1600. 10.1002/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#.PubMedCrossRef
25.
Zurück zum Zitat Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275: 1943-1947. 10.1126/science.275.5308.1943.PubMedCrossRef Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275: 1943-1947. 10.1126/science.275.5308.1943.PubMedCrossRef
26.
Zurück zum Zitat Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pan-dolfi PP: Impaired Fas response and autoimmunity in Pten+/-mice. Science. 1999, 285: 2122-2125. 10.1126/science.285.5436.2122.PubMedCrossRef Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pan-dolfi PP: Impaired Fas response and autoimmunity in Pten+/-mice. Science. 1999, 285: 2122-2125. 10.1126/science.285.5436.2122.PubMedCrossRef
27.
Zurück zum Zitat Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT: Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994, 37: 212-220.PubMedCrossRef Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT: Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994, 37: 212-220.PubMedCrossRef
28.
Zurück zum Zitat Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, Wilder RK, Kato H, Kondo M, Nakajima H: C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 1999, 42: 954-962. 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J.PubMedCrossRef Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, Wilder RK, Kato H, Kondo M, Nakajima H: C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 1999, 42: 954-962. 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J.PubMedCrossRef
29.
Zurück zum Zitat Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N: Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nature Med. 1999, 5: 760-767. 10.1038/10480.PubMedCrossRef Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N: Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nature Med. 1999, 5: 760-767. 10.1038/10480.PubMedCrossRef
30.
Zurück zum Zitat Aicher WK, Heer AH, Trabandt A, Bridges SL, Schroeder HW, Stransky G, Gay RE, Eibel H, Peter HH, Slebenlist U, Gay S: Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol. 1994, 152: 5940-5948.PubMed Aicher WK, Heer AH, Trabandt A, Bridges SL, Schroeder HW, Stransky G, Gay RE, Eibel H, Peter HH, Slebenlist U, Gay S: Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol. 1994, 152: 5940-5948.PubMed
31.
Zurück zum Zitat Nykanen P, Bergroth V, Raunio P, Nordstrom D, Konttinen YT: Phenotypic characterization of 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane. Rheumatol Int. 1986, 6: 269-271.PubMedCrossRef Nykanen P, Bergroth V, Raunio P, Nordstrom D, Konttinen YT: Phenotypic characterization of 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane. Rheumatol Int. 1986, 6: 269-271.PubMedCrossRef
32.
Zurück zum Zitat Mohr W, Hummler N, Peister B, Wessinghage D: Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int. 1986, 6: 127-132.PubMedCrossRef Mohr W, Hummler N, Peister B, Wessinghage D: Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int. 1986, 6: 127-132.PubMedCrossRef
34.
Zurück zum Zitat Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 1995, 38: 485-491.PubMedCrossRef Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 1995, 38: 485-491.PubMedCrossRef
35.
Zurück zum Zitat Kobayashi T, Okamoto K, Kobata T, Hasumuna T, Nishioka K: Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol. 1999, 11: 188-193. 10.1097/00002281-199905000-00007.PubMedCrossRef Kobayashi T, Okamoto K, Kobata T, Hasumuna T, Nishioka K: Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol. 1999, 11: 188-193. 10.1097/00002281-199905000-00007.PubMedCrossRef
36.
Zurück zum Zitat Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Müller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel anti-apoptotic molecule at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 599-607. 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T.PubMedCrossRef Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Müller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel anti-apoptotic molecule at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 599-607. 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T.PubMedCrossRef
37.
Zurück zum Zitat Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET: Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol. 1996, 157: 4277-4281.PubMed Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET: Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol. 1996, 157: 4277-4281.PubMed
38.
Zurück zum Zitat Rinaldi N, Schwarz EM, Weis D, Leppelmann JP, Lukoschek M, Keilholz U, Barth TF: Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis. 1997, 56: 45-51.PubMedPubMedCentralCrossRef Rinaldi N, Schwarz EM, Weis D, Leppelmann JP, Lukoschek M, Keilholz U, Barth TF: Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis. 1997, 56: 45-51.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Ishikawa H, Hirata S, Andoh Y, Kubo H, Nakagawa N, Nishibayashi Y, Mizuno K: An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis. Rheumatol Int. 1996, 16: 53-60.PubMedCrossRef Ishikawa H, Hirata S, Andoh Y, Kubo H, Nakagawa N, Nishibayashi Y, Mizuno K: An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis. Rheumatol Int. 1996, 16: 53-60.PubMedCrossRef
40.
Zurück zum Zitat Müller-Ladner U, Elices MJ, Kriegsmann J, Strahl D, Gay RE, Firestein GS, Gay S: Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. J Rheumatol . 1997, 24: 1873-1880.PubMed Müller-Ladner U, Elices MJ, Kriegsmann J, Strahl D, Gay RE, Firestein GS, Gay S: Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. J Rheumatol . 1997, 24: 1873-1880.PubMed
42.
Zurück zum Zitat Dike LE, Farmer SR: Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts. Proc Natl Acad Sci USA. 1988, 85: 6792-6796.PubMedPubMedCentralCrossRef Dike LE, Farmer SR: Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts. Proc Natl Acad Sci USA. 1988, 85: 6792-6796.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Dike LE, Ingber DE: Integrin-dependent induction of early growth response genes in capillary endothelial cells. J Cell Sci. 1996, 109: 2855-2863.PubMed Dike LE, Ingber DE: Integrin-dependent induction of early growth response genes in capillary endothelial cells. J Cell Sci. 1996, 109: 2855-2863.PubMed
44.
Zurück zum Zitat Parks WC, Mecham RP: . Matrix Metalloproteinases. San Diego: Academic Press. 1998 Parks WC, Mecham RP: . Matrix Metalloproteinases. San Diego: Academic Press. 1998
45.
Zurück zum Zitat Müller-Ladner U, Gay RE, Gay S: Cysteine proteinases in arthritis and inflammation. Perspect Drug Discovery Design. 1996, 6: 87-98.CrossRef Müller-Ladner U, Gay RE, Gay S: Cysteine proteinases in arthritis and inflammation. Perspect Drug Discovery Design. 1996, 6: 87-98.CrossRef
46.
Zurück zum Zitat Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher L: In situ hybridization studies on stromelysin and collagenase mRNA expression in rheumatoid synovium. Arthritis Rheum . 1991, 34: 1071-1084.CrossRef Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher L: In situ hybridization studies on stromelysin and collagenase mRNA expression in rheumatoid synovium. Arthritis Rheum . 1991, 34: 1071-1084.CrossRef
47.
Zurück zum Zitat Firestein GS, Paine M: Expression of stromelysin and TIMP in rheumatoid arthritis synovium. Am J Pathol. 1992, 140: 1309-1314.PubMedPubMedCentral Firestein GS, Paine M: Expression of stromelysin and TIMP in rheumatoid arthritis synovium. Am J Pathol. 1992, 140: 1309-1314.PubMedPubMedCentral
48.
Zurück zum Zitat Konttinen YT, Ceponis A, Takagi M, Ainola M, Sorsa T, Sutinen M, Salo T, Ma J, Santavirta S, Seiki M: New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol. 1998, 17: 585-601. 10.1016/S0945-053X(98)90110-X.PubMedCrossRef Konttinen YT, Ceponis A, Takagi M, Ainola M, Sorsa T, Sutinen M, Salo T, Ma J, Santavirta S, Seiki M: New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol. 1998, 17: 585-601. 10.1016/S0945-053X(98)90110-X.PubMedCrossRef
49.
Zurück zum Zitat Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S: Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol. 1996, 23: 885-889.PubMedCrossRef Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S: Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol. 1996, 23: 885-889.PubMedCrossRef
50.
Zurück zum Zitat Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, López-Otín C: Matrix-metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 1997, 40: 1391-1399.PubMedCrossRef Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, López-Otín C: Matrix-metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 1997, 40: 1391-1399.PubMedCrossRef
51.
Zurück zum Zitat Clark IM, Powell LK, Ramsey S, Hazelman BL, Cawston TE: The measurement of collagenase, TIMP and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993, 36: 372-380.PubMedCrossRef Clark IM, Powell LK, Ramsey S, Hazelman BL, Cawston TE: The measurement of collagenase, TIMP and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993, 36: 372-380.PubMedCrossRef
52.
Zurück zum Zitat Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989, 48: 645-653.PubMedPubMedCentralCrossRef Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989, 48: 645-653.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, Pap T, gay S, Stiehl P, Gromnica-Ihle E, Wernicke D: Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1517-1527. 10.1002/1529-0131(199907)42:7<1517::AID-ANR27>3.0.CO;2-G.PubMedCrossRef Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, Pap T, gay S, Stiehl P, Gromnica-Ihle E, Wernicke D: Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1517-1527. 10.1002/1529-0131(199907)42:7<1517::AID-ANR27>3.0.CO;2-G.PubMedCrossRef
54.
Zurück zum Zitat Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S: Differential expression of membrane-type matrix metalloproteinases (MT-MMPs) in rheumatoid arthritis (RA). Arthritis Rheum. 2000, 43: 1226-1232. 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4.PubMedCrossRef Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S: Differential expression of membrane-type matrix metalloproteinases (MT-MMPs) in rheumatoid arthritis (RA). Arthritis Rheum. 2000, 43: 1226-1232. 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4.PubMedCrossRef
55.
Zurück zum Zitat Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994, 370: 61-65. 10.1038/370061a0.PubMedCrossRef Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994, 370: 61-65. 10.1038/370061a0.PubMedCrossRef
56.
Zurück zum Zitat Cunnane G, Fitzgerald O, Hummel KM, Gay RE, Gay S, Bresnihan B: Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology (Oxford). 1999, 38: 34-42. 10.1093/rheumatology/38.1.34.CrossRef Cunnane G, Fitzgerald O, Hummel KM, Gay RE, Gay S, Bresnihan B: Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology (Oxford). 1999, 38: 34-42. 10.1093/rheumatology/38.1.34.CrossRef
57.
Zurück zum Zitat Lemaire R, Flipo RM, Monte D, Dupressoir T, Duquesnoy B, Cesbron JY, Janin A, Capron A, Lafyatis R: Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice. J Rheumatol. 1994, 21: 1409-1419.PubMed Lemaire R, Flipo RM, Monte D, Dupressoir T, Duquesnoy B, Cesbron JY, Janin A, Capron A, Lafyatis R: Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice. J Rheumatol. 1994, 21: 1409-1419.PubMed
58.
Zurück zum Zitat Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson HM, Hamilton RT, McGhee JR, Fassbender HG, Gay S: Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix. 1990, 10: 349-361.PubMedCrossRef Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson HM, Hamilton RT, McGhee JR, Fassbender HG, Gay S: Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix. 1990, 10: 349-361.PubMedCrossRef
59.
Zurück zum Zitat Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, Flipo RM: Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol. 1997, 36: 735-743. 10.1093/rheumatology/36.7.735.PubMedCrossRef Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, Flipo RM: Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol. 1997, 36: 735-743. 10.1093/rheumatology/36.7.735.PubMedCrossRef
60.
Zurück zum Zitat Huet G, Flipo RM, Colin C, Janin A, Hemon B, Collyn dM, Lafyatis R, Duquesnoy B, Degand P: Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum. 1993, 36: 772-780.PubMedCrossRef Huet G, Flipo RM, Colin C, Janin A, Hemon B, Collyn dM, Lafyatis R, Duquesnoy B, Degand P: Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum. 1993, 36: 772-780.PubMedCrossRef
61.
Zurück zum Zitat Hummel KM, Petrow PK, Franz JK, Müller-Ladner U, Aicher WK, Gay RE, Brömme D, Gay S: Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol. 1998, 25: 1887-1894.PubMed Hummel KM, Petrow PK, Franz JK, Müller-Ladner U, Aicher WK, Gay RE, Brömme D, Gay S: Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol. 1998, 25: 1887-1894.PubMed
62.
Zurück zum Zitat Brennan FM, Browne KA, Green PA, Jaspar JM, Maini RN, Feldmann M: Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol. 1997, 36: 643-650. 10.1093/rheumatology/36.6.643.PubMedCrossRef Brennan FM, Browne KA, Green PA, Jaspar JM, Maini RN, Feldmann M: Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol. 1997, 36: 643-650. 10.1093/rheumatology/36.6.643.PubMedCrossRef
63.
Zurück zum Zitat Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M: TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis. APMIS. 1997, 105: 257-263.PubMedCrossRef Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M: TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis. APMIS. 1997, 105: 257-263.PubMedCrossRef
64.
Zurück zum Zitat Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med . 1997, 337: 141-147. 10.1056/NEJM199707173370301.PubMedCrossRef Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med . 1997, 337: 141-147. 10.1056/NEJM199707173370301.PubMedCrossRef
65.
Zurück zum Zitat Alsalameh S, Winter K, A-Ward R, Wendler J, Kalden JR, Kinne RW: Distribution of TNF-α, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-α is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol . 1999, 49: 278-285. 10.1046/j.1365-3083.1999.00458.x.PubMedCrossRef Alsalameh S, Winter K, A-Ward R, Wendler J, Kalden JR, Kinne RW: Distribution of TNF-α, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-α is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol . 1999, 49: 278-285. 10.1046/j.1365-3083.1999.00458.x.PubMedCrossRef
66.
Zurück zum Zitat Kuiper S, Joosten LA, Bendele AM, Edwards CK, Arntz O, Helsen M, van de Loo FA, van den Berg BW: Different roles of TNFα and IL-1 in murine streptococcal wall arthritis. Cytokine . 1998, 10: 690-702. 10.1006/cyto.1998.0372.PubMedCrossRef Kuiper S, Joosten LA, Bendele AM, Edwards CK, Arntz O, Helsen M, van de Loo FA, van den Berg BW: Different roles of TNFα and IL-1 in murine streptococcal wall arthritis. Cytokine . 1998, 10: 690-702. 10.1006/cyto.1998.0372.PubMedCrossRef
67.
Zurück zum Zitat Bendele A, Sennello G, McAbee T, Frazier J, Chlipala E, Rich B: Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats. J Rheumatol. 1999, 26: 1225-1229.PubMed Bendele A, Sennello G, McAbee T, Frazier J, Chlipala E, Rich B: Effects of interleukin 1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats. J Rheumatol. 1999, 26: 1225-1229.PubMed
68.
Zurück zum Zitat Goldring SR, Gravallese EM: Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000, 2: 33-37. 10.1186/ar67.PubMedPubMedCentralCrossRef Goldring SR, Gravallese EM: Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res. 2000, 2: 33-37. 10.1186/ar67.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Shigeyama Y, Pap T, Kunzler P, Rethage J, Simmen B, Gay RE, Gay S: Rheumatoid arthritis (RA) synovial fibroblasts express osteoclast differentiating factor (ODF) mRNA at sites of joint destruction [abstract]. Arthritis Rheum. 1999, 42: S283- Shigeyama Y, Pap T, Kunzler P, Rethage J, Simmen B, Gay RE, Gay S: Rheumatoid arthritis (RA) synovial fibroblasts express osteoclast differentiating factor (ODF) mRNA at sites of joint destruction [abstract]. Arthritis Rheum. 1999, 42: S283-
70.
Zurück zum Zitat Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP: Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 1999, 42: 650-658. 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S.PubMedCrossRef Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP: Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 1999, 42: 650-658. 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S.PubMedCrossRef
71.
Zurück zum Zitat Franz JK, Kolb S, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16 produced by synovial fibroblasts mediates chemoattraction to CD4+ T-cells in rheumatoid arthritis. Eur J Immunol. 1998, 28: 2661-2671. 10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N.PubMedCrossRef Franz JK, Kolb S, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16 produced by synovial fibroblasts mediates chemoattraction to CD4+ T-cells in rheumatoid arthritis. Eur J Immunol. 1998, 28: 2661-2671. 10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N.PubMedCrossRef
72.
Zurück zum Zitat Ogasawara H, Takeda-Hirokawa N, Sekigawa I, Hashimoto H, Kaneko Y, Hirose S: Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells. Immunology. 1999, 96: 215-219. 10.1046/j.1365-2567.1999.00693.x.PubMedPubMedCentralCrossRef Ogasawara H, Takeda-Hirokawa N, Sekigawa I, Hashimoto H, Kaneko Y, Hirose S: Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells. Immunology. 1999, 96: 215-219. 10.1046/j.1365-2567.1999.00693.x.PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Salmon M, Scheel Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest. 1997, 99: 439-446.PubMedPubMedCentralCrossRef Salmon M, Scheel Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest. 1997, 99: 439-446.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Lindhout E, van Eijk M, van Pel M, Lindeman J, Dinant HJ, de Groot C: Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol. 1999, 162: 5949-5956.PubMed Lindhout E, van Eijk M, van Pel M, Lindeman J, Dinant HJ, de Groot C: Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol. 1999, 162: 5949-5956.PubMed
75.
Zurück zum Zitat Müller-Ladner U, Evans CH, Franklin BN, Roberts CR, Gay RE, Robbins PD, Gay S: Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum. 1999, 42: 490-497. 10.1002/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L.PubMedCrossRef Müller-Ladner U, Evans CH, Franklin BN, Roberts CR, Gay RE, Robbins PD, Gay S: Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum. 1999, 42: 490-497. 10.1002/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L.PubMedCrossRef
76.
Zurück zum Zitat Jorgensen C, Gay S: Gene therapy in osteoarticular diseases: where are we?. Immunol Today. 1998, 19: 387-391. 10.1016/S0167-5699(98)01296-1.PubMedCrossRef Jorgensen C, Gay S: Gene therapy in osteoarticular diseases: where are we?. Immunol Today. 1998, 19: 387-391. 10.1016/S0167-5699(98)01296-1.PubMedCrossRef
77.
Zurück zum Zitat Pap T, Müller-Ladner U, Gay RE, Gay S: Gene therapy in rheumatoid arthritis: how to target joint destruction?. Arthritis Res. 1999, 1: 5-9. 10.1186/ar3.PubMedPubMedCentralCrossRef Pap T, Müller-Ladner U, Gay RE, Gay S: Gene therapy in rheumatoid arthritis: how to target joint destruction?. Arthritis Res. 1999, 1: 5-9. 10.1186/ar3.PubMedPubMedCentralCrossRef
Metadaten
Titel
Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
verfasst von
Thomas Pap
Ulf Müller-Ladner
Renate E Gay
Steffen Gay
Publikationsdatum
01.08.2000
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 5/2000
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar113

Weitere Artikel der Ausgabe 5/2000

Arthritis Research & Therapy 5/2000 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.